2.9. Plaque-Reduction Neutralization Test for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

HK Hye-Jung Kim
HK Hye Won Kwak
KK Kyung Won Kang
YB Yoo-Jin Bang
YL Yu-Sun Lee
HP Hyeong-Jun Park
JK Jae-Yong Kim
HP Hyo-Jung Park
KH Kyung-Ah Hwang
SL Sang-Myeong Lee
JN Jae-Hwan Nam
ask Ask a question
Favorite

The serum samples from vaccinated mice were inactivated at 56 °C for 30 min. The samples were serially diluted from 1/40 to 1/640 with serum-free medium. The virus–serum mixture was prepared by mixing 125 PFU MERS-CoV with the diluted serum samples and incubated at 37 °C for 1 h. The virus–antibody mixture was inoculated into Vero cells. The plates were incubated for 1 h at 37 °C in 5% CO2. After virus adsorption, agar overlay medium was added, and the plates were incubated at 37 °C in 5% CO2 for four days. The cells were stained with 0.4% crystal violet solution (Sigma, St. Louis, MO, USA). Plaques were counted with the naked eye. The percentage neutralization represented the reduction value, which was calculated as 100× the number of plaques in the 100 PFU virus-infected well/ number of plaques in the virus–serum mixture-infected well.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A